Lack of efficacy (protozoa) - NOS

Verify with FDA CVM →

VeDDRA Code: 2655

663 adverse event reports referencing this reaction

663
Total Reports
61
Deaths
920.0%
Death Rate

Species Most Affected

Dog 493
Cat 98
Horse 59
Cattle 10
Guinea Pig 1
Chicken 1
Macaw 1

Breeds Most Affected

Retriever - Labrador 86
Domestic Shorthair 70
Crossbred Canine/dog 47
Retriever - Golden 39
Shepherd Dog - German 35
Shepherd Dog - Australian 18
Beagle 17
Quarter Horse 16
Collie - Border 12
Terrier - Yorkshire 11

Associated Drugs

Ivermectin + Pyrantel As Pamoate Salt 161
Milbemycin Oxime, Lufenuron 48
Fenbendazol Granules 39
Fluralaner Spot-On Solution 39
Milbemycin Oxime + Spinosad 37
Fluralaner/Moxidectin Spot-On 36
Diclazuril Oral Pellets 29
Milbemycin Oxime 22
Ponazuril 20
Lufenuron + Milbemycin Oxime 19
Milbemycin 18
Selamectin 17
Pyrantel Pamoate;Sarolaner 16
Ivermectin/Pyrantel Pamoate Chewable 272Mcg/652Mg 15
Ivermectin/Pyrantel Pamoate Chewable 68Mcg/163Mg 14
Milbemcyin Oxime, Lufenuron, Praziquantel 14
Ivermectin, Pyrantel 13
Ivermectin/Pyrantel Pamoate Chewable 136Mcg/326Mg 13
Milbemycin, Lufenuron 10
Ivermectin + Pyrantel 8

Data Summary

Metric Value
Total reports referencing reaction 663
Reports with fatal outcome 61
Case-fatality rate (reported events) 920.0%
Species observed 7
Breeds observed 20
Drugs associated with reaction 20

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER); reaction term coded under VeDDRA 2655.

Lack of efficacy (protozoa) - NOS Reaction Insights

The FDA Center for Veterinary Medicine database currently lists 663 adverse event reports that reference Lack of efficacy (protozoa) - NOS as a reaction term, including 61 reports with a death outcome — a 920.0% case-fatality figure calculated across only those events where this reaction was coded. The reaction is indexed in the openFDA system under VeDDRA code 2655, the standardized veterinary dictionary used to normalize clinical signs across submitters. Because reports are voluntary and often describe multiple concurrent signs per animal, the volume here reflects reporting intensity rather than true incidence in the broader pet population.

Lack of efficacy (protozoa) - NOS appears most frequently in reports for Dog (493 reports), Cat (98 reports), Horse (59 reports) — with Dog dominating at 493 entries. Within those species, the breeds most often named alongside this reaction are Retriever - Labrador (86), Domestic Shorthair (70), Crossbred Canine/dog (47). These distributions are influenced both by underlying breed popularity and by how veterinarians and owners code a given clinical sign, so they should be interpreted as a reporting fingerprint rather than a pure susceptibility ranking.

The drugs most commonly co-reported with Lack of efficacy (protozoa) - NOS are Ivermectin + Pyrantel As Pamoate Salt (161 reports), Milbemycin Oxime, Lufenuron (48 reports), Fenbendazol Granules (39 reports), Fluralaner Spot-On Solution (39 reports), with Ivermectin + Pyrantel As Pamoate Salt appearing alongside this reaction in 161 submissions. Co-reporting does not establish that any specific product caused the reaction — FDA CVM data captures temporal association only. The value of these aggregates is in flagging which therapeutic classes appear repeatedly alongside a given clinical sign, so owners and veterinarians can ask targeted questions about medications currently in use.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial